Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mini-scleral lens comfort with Systane drops versus saline
ACTRN12619000274178Phase 4Completed
- Sponsor
- University of New South Wales
- Start
- Apr 2019
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Contact lens discomfort (CLD) comparing Systane Complete, Systane Hydration and Saline control (3 arms). Primary endpoint: Subjective comfort rating. Started Apr 2019; status: completed.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsionSystane HYDRATIONsaline
03
Conditions
Contact lens discomfort (CLD)
Beyond the preview
Go deeper on ACTRN12619000274178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000274178.